SWA
ICPT

Sutton Wealth Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Sutton Wealth Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-82
Closed -$13.5K – 1085
2016
Q3 		$13.5K Hold
82
– – 0.01% 578
2016
Q2 		$11.7K Hold
82
– – 0.01% 583
2016
Q1 		$10.5K Buy
+82
New +$9.68K 0.01% 604

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Sutton Wealth Advisors's ICPT Position: Q4 2016 in Review

Sutton Wealth Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2016, closing a stake of 82 shares — an estimated $13.5K sold.

Sutton Wealth Advisors first reported a position in ICPT in Q1 2016 and held it in 3 quarters. The position peaked at $13.5K in Q3 2016. 159 funds tracked by Wall St. Rank hold ICPT as of Q4 2016.

  • Sutton Wealth Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Sutton Wealth Advisors sold 82 Intercept Pharmaceuticals, Inc. shares in Q4 2016, an estimated $13.5K.
  • Sutton Wealth Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2016 and held it in 3 quarters.
  • Sutton Wealth Advisors's Intercept Pharmaceuticals, Inc. position peaked at $13.5K in Q3 2016.
  • 159 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2016.

Based on Sutton Wealth Advisors's 13F filing for Q4 2016, filed 6 Nov 2023.